Skip to content
Screener

ANI Pharmaceuticals ANIP Gross Carrying Amount

Gross Carrying Amount at other companies

Viatris logo
ViatrisVTRS
$33.82B-3.1%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$20.42M+0.9%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$321.59M+12.2%

Other financials

Income statement

See full
Revenue$266.0M+25.9%
Gross profit$165.9M+21.3%
Operating income$40.5M+191%
Net income$24.7M+189%
EPS (diluted)$1.05+192%

Balance sheet

See full
Cash & equivalents$360.2M+65.4%
Total debt$301.5M-4.2%
Total equity$597.2M+36.7%
Total assets$1.5B+11.3%

Cash flow

See full
Operating cash flow$56.7M-25.3%
CapEx$3.1M-23.9%
Free cash flow$53.6M-25.3%

Valuation

See full
Market cap$1.78B+0.8%
Enterprise value$1.72B-7.6%
P/E16.4×
P/S1.8×-0.5×

Profitability

See full
Gross margin60.4%-0.7pp
Operating margin15.4%
Net margin11.1%+10.0pp
FCF margin17.7%+0.9pp

Returns & leverage

See full
Return on equity21%+19.1pp
Debt / equity0.5×-0.2×
Current ratio2.9×+0.4×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 7:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001023024-26-000069
(in thousands)June 30, 2026 / Gross Carrying AmountJune 30, 2026 / Accumulated AmortizationJune 30, 2026 / Net Carrying AmountDecember 31, 2025 / Gross Carrying AmountDecember 31, 2025 / Accumulated AmortizationDecember 31, 2025 / Net Carrying AmountRemaining Weighted Average Amortization Period (1)
Definite-Lived Intangible Assets:
Acquired ANDAs intangible assets$214,417$(158,199)$56,218$214,260$(147,511)$66,7493.3 years
NDAs and product rights679,804(294,946)384,858673,554(271,818)401,7369.8 years
Marketing and distribution rights17,157(16,676)48117,157(16,195)9620.5 years
Customer relationships24,900(16,600)8,30024,900(14,821)10,0792.3 years
Total Intangible Assets, net$936,278$(486,421)$449,857$929,871$(450,345)$479,5268.8 years

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is ANI Pharmaceuticals's gross carrying amount?
ANI Pharmaceuticals (ANIP) reported gross carrying amount of $936.28M in Q2 2026.
How has ANI Pharmaceuticals's gross carrying amount changed year-over-year?
ANI Pharmaceuticals's gross carrying amount increased by 0.7% year-over-year, from $929.89M to $936.28M.
What is the long-term trend for ANI Pharmaceuticals's gross carrying amount?
Over 3 years (2022 to 2025), ANI Pharmaceuticals's gross carrying amount has grown at a 24.6% compound annual growth rate (CAGR), from $480.92M to $929.87M.
What does gross carrying amount mean?
Gross Carrying Amount

Ask your AI about ANI Pharmaceuticals's gross carrying amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude